Sana Biotechnology Inc vs SYSCO Corporation — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while SYSCO Corporation trades at $81.33 (market cap $38.63B). The key difference: SYSCO Corporation is far larger — about 44.2× Sana Biotechnology Inc's market cap, and SYSCO Corporation pays a 2.72% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SYY | |
|---|---|---|
Market Cap | $873.84M | $38.63B |
Sector | Health | Consumer Staples |
52-Week High | $5.92 | $91.16 |
52-Week Low | $2.68 | $69.30 |
Enterprise Value | $848.03M | $52.11B |
Dividend Yield | — | 2.72% |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →